Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
First Solar
FSLR
$24.2B
| $9.41M | ﹤0.01% |
190,088
-630,121
| -77% | -$28.1M |
|
|
EGRX
2152
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.4M | ﹤0.01% |
195,878
+188,085
| +2,414% | +$9.38M |
|
2153
Ligand Pharmaceuticals
LGND
$5.87B
| $9.39M | ﹤0.01% |
134,615
-169,682
| -56% | -$10.8M |
|
2154
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $9.39M | ﹤0.01% |
180,582
-77,295
| -30% | -$3.91M |
|
2155
CALL
Enbridge
ENB
$111B
| $9.38M | ﹤0.01% |
308,500
-6,400
| -2% | -$197K |
|
2156
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $9.36M | ﹤0.01% |
+371,365
| New | +$9.15M |
|
2157
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.18B
| $9.36M | ﹤0.01% |
295,198
+190,451
| +182% | +$5.8M |
|
2158
Bright Horizons
BFAM
$3.75B
| $9.35M | ﹤0.01% |
+79,796
| New | +$9.11M |
|
2159
iShares Russell 1000 Growth ETF
IWF
$128B
| $9.34M | ﹤0.01% |
+194,612
| New | +$8.58M |
|
2160
Direxion Daily Energy Bull 2X ETF
ERX
$251M
| $9.33M | ﹤0.01% |
618,265
+551,666
| +828% | +$8.33M |
|
2161
Fidelity MSCI Energy Index ETF
FENY
$2.09B
| $9.32M | ﹤0.01% |
+939,117
| New | +$9.12M |
|
2162
AeroVironment
AVAV
$9.76B
| $9.32M | ﹤0.01% |
117,075
-2,906
| -2% | -$187K |
|
2163
PUT
Masco
MAS
$14.7B
| $9.32M | ﹤0.01% |
185,600
+5,000
| +3% | +$217K |
|
2164
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $9.32M | ﹤0.01% |
30,216
-788,929
| -96% | -$231M |
|
2165
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $9.32M | ﹤0.01% |
295,381
+157,953
| +115% | +$4.77M |
|
2166
CALL
Zions Bancorporation
ZION
$10.5B
| $9.32M | ﹤0.01% |
274,000
-46,000
| -14% | -$1.46M |
|
2167
PUT
Takeda Pharmaceutical
TAK
$56.3B
| $9.31M | ﹤0.01% |
519,200
+10,400
| +2% | +$187K |
|
2168
CALL
Allegiant Air
ALGT
$2.34B
| $9.3M | ﹤0.01% |
85,200
+52,000
| +157% | +$4.75M |
|
2169
Carvana
CVNA
$83.1B
| $9.29M | ﹤0.01% |
386,435
+171,635
| +80% | +$3.21M |
|
|
AUTL
2170
Autolus Therapeutics
AUTL
$572M
| $9.29M | ﹤0.01% |
579,344
-2,360
| -0.4% | -$26.2K |
|
2171
United States Natural Gas Fund
UNG
$487M
| $9.29M | ﹤0.01% |
226,269
+26,418
| +13% | +$1.26M |
|
2172
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $9.28M | ﹤0.01% |
583,500
-146,700
| -20% | -$2.35M |
|
2173
ScottsMiracle-Gro
SMG
$3.55B
| $9.27M | ﹤0.01% |
68,956
-18,730
| -21% | -$2.42M |
|
2174
PUT
Steel Dynamics
STLD
$36.7B
| $9.27M | ﹤0.01% |
355,300
+3,300
| +0.9% | +$82.5K |
|
2175
CALL
Ralph Lauren
RL
$23.2B
| $9.27M | ﹤0.01% |
127,800
+16,600
| +15% | +$1.22M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.